Suchergebnisse - "Pariente, Benjamin"

PubPharm (8)

1

Ustekinumab for Perianal Crohn's Disease : The BioLAP Multicenter Study From the GETAID

enthalten in: The American journal of gastroenterology | 2020

von Chapuis-Biron, C. | Kirchgesner, J. | Pariente, B. | +23

2

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

enthalten in: Gastroenterology | 2020

von Ungaro, R. | Yzet, C. | Bossuyt, P. | +36

3

Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Engel, T. | Yung, D. | Ma, C. | +6

4

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Pouillon, L. | Lamoureux, A. | Pineton de Chambrun, G. | +10

CommentIn: Dig Liver Dis. 2019 Apr;51(4):609-610. - PMID 30862437

5

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

enthalten in: Gastroenterology | 2018

von D'Haens, G. | Vermeire, S. | Lambrecht, G. | +27

CommentIn: Gastroenterology. 2018 Oct;155(4):1277-1278. - PMID 30222942

6

Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2017

von Duveau, N. | Nachury, M. | Gerard, R. | +6

7

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents

enthalten in: Autoimmunity reviews | 2014

von Fiorino, G. | Danese, S. | Pariente, B. | +1

8

Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

enthalten in: Inflammatory bowel diseases | 2012

von Pariente, B. | Pineton de Chambrun, G. | Krzysiek, R. | +9

1
[1]